Rigel Pharmaceuticals (RIGL) Raw Materials (2021 - 2026)

Rigel Pharmaceuticals' Raw Materials history runs 6 years deep, the most recent figure standing at $3.4 million for Q1 2026.

• In Q1 2026, Raw Materials rose 218.2% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at $3.4 million (up 218.2% YoY), while the FY2025 annual figure was $4.5 million, up 319.13% from the prior year.
• Raw Materials was $3.4 million for Q1 2026 at Rigel Pharmaceuticals, down from $4.5 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $9.6 million in Q2 2025 to a low of $1.1 million in Q4 2024.
• Historically, Raw Materials has averaged $4.4 million across 5 years, with a median of $4.6 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Raw Materials tumbled 76.63% in 2024, then surged 348.76% in 2025.
• A 5-year view of Raw Materials shows it stood at $4.6 million in 2022, then climbed by 1.19% to $4.6 million in 2023, then sank by 76.63% to $1.1 million in 2024, then surged by 319.13% to $4.5 million in 2025, then dropped by 24.08% to $3.4 million in 2026.
• The last three Raw Materials figures came in at $3.4 million (Q1 2026), $4.5 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.